Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases

被引：20
|
作者：
Papamichael, Konstantinos [1 ]
Clarke, William T. [1 ]
Vande Casteele, Niels [2 ]
Germansky, Katharine A. [1 ]
Feuerstein, Joseph D. [1 ]
Melmed, Gil Y. [3 ]
Siegel, Corey A. [4 ]
Irving, Peter M. [5 ]
Cheifetz, Adam S. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA
[4] Dartmouth Hitchcock Med Ctr, Dept Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[5] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol & Hepatol, London, England
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 19卷 / 04期
关键词：
D O I：
10.1016/j.cgh.2020.03.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：839 / +
页数：5
相关论文
共 50 条
  • [31] Therapeutic drug monitoring in Paediatric inflammatory bowel disease on maintenance infliximab and adalimumab treatment improves clinical remission with a proactive approach
    Chadokufa, S.
    Sider, S.
    Huggett, B.
    Sawney, T.
    Shah, N.
    Baycheva, M.
    Perez, A. Zambrano
    Acton, N.
    Kiparissi, F.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S381 - S382
  • [32] Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease
    Gil Candel, Mayte
    Gascon Canovas, Juan Jose
    Urbieta Sanz, Elena
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (05) : 360 - 366
  • [33] Proactive Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease Patients Receiving Infliximab and Biosimilars
    Aktay, Atiye
    Odolil, Abel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S21 - S21
  • [34] Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
    Lorant Gonczi
    Zsuzsanna Kurti
    Mariann Rutka
    Zsuzsanna Vegh
    Klaudia Farkas
    Barbara D. Lovasz
    Petra A. Golovics
    Krisztina B. Gecse
    Balazs Szalay
    Tamas Molnar
    Peter L. Lakatos
    BMC Gastroenterology, 17
  • [35] Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
    Gonczi, Lorant
    Kurti, Zsuzsanna
    Rutka, Mariann
    Vegh, Zsuzsanna
    Farkas, Klaudia
    Lovasz, Barbara D.
    Golovics, Petra A.
    Gecse, Krisztina B.
    Szalay, Balazs
    Molnar, Tamas
    Lakatos, Peter L.
    BMC GASTROENTEROLOGY, 2017, 17
  • [36] Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
    Kurti, Z.
    Rutka, M.
    Vegh, Z.
    Gonczi, L.
    Farkas, K.
    Lovasz, B. D.
    Gecse, K. B.
    Golovics, A.
    Szalay, B.
    Molnar, T.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S286 - S286
  • [37] Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Melmed, Gil Y.
    Irving, Peter M.
    Casteele, Niels Vande
    Kozuch, Patricia L.
    Raffals, Laura E.
    Baidoo, Leonard
    Bressler, Brian
    Devlin, Shane M.
    Jones, Jennifer
    Kaplan, Gilaad G.
    Sparrow, Miles P.
    Velayos, Fernando S.
    Ullman, Thomas
    Siegel, Corey A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1655 - +
  • [38] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    不详
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [39] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [40] Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study
    Singh, Siddharth
    Andersen, Nynne Nyboe
    Andersson, Mikael
    Loftus, Edward V., Jr.
    Jess, Tine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
12345